PNF Method for Those Working in Special Education

June 17, 2024 updated by: ebrar atak, Istanbul Medipol University Hospital

Acute Effect of Self-PNF Stretching on Chest Mobility, Posterior Muscle Chain Mobility and Respiratory Functions in Caregivers of Children With Developmental Delays

The aim of the study was to examine the acute effect of self-proprioceptive neuromuscular facilitation (PNF) stretching on chest mobility, posterior muscle chain mobility and respiratory functions in caregivers of children with developmental delays. In the study: 1. Does self-PNF stretching have an effect on chest mobility and posterior muscle chain mobility in caregivers of children with developmental delay? 2. Does self-PNF stretching have an effect on respiratory functions in caregivers of children with developmental delays? The questions were answered.

Study Overview

Status

Completed

Conditions

Detailed Description

A cross-over randomized controlled study was designed with 30 caregivers of children with developmental disabilities. Using the online randomization method, caregivers were first assigned to either the PNF stretching group or the static stretching group. Before and after the application, rib cage mobility was evaluated by chest circumference measurement, hamstring muscle mobility by popliteal angle measurement, lumbar region mobility by Schober Test, posterior muscle chain mobility by Finger-Floor Distance Measurement Test, and respiratory functions by Respiratory Function Test. The caregiver, who entered a 1-day cleansing period, repeated the evaluation and technique application with the stretching technique that was not applied the next day.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Yalova, Turkey, 77100
        • Ebrar Atak

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Volunteering to participate in the study
  • No history of infection or flare in the previous 4 weeks
  • Participants who have not been included in another clinical trial in the last month
  • Those whose knee flexion angle is 15 degrees and above in the hamstring muscle shortness test

Exclusion Criteria:

  • Vestibular disorders, participants with known balance impairment within the past three months due to concussion
  • Those with musculoskeletal system problems in their lower extremities
  • Those who had lower extremity and thorax surgery in the last year
  • Those with metabolic diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PNF Stretching Group
The PNF stretching method for each muscle was applied to the athlete in the form of self-stretching by the participant, with the direct treatment concept of hold and relax technique, with the training of a specialist physiotherapist. The muscle to be stretched (the antagonist muscle for the pattern - the muscle that causes the limitation) was first brought to the position where it could be extended, and at that point, the stretched muscle was contracted submaximally (65% of the intensity determined according to the Stretch Intensity Scale) for 5 seconds, causing isometric contraction. Then, the athlete was given 5 relax commands for the tense muscle. Then, the stretched muscle was stretched as far as it could go, and the muscle that needed to be stretched was passively stretched for 20 seconds (1 set). After a 5-second rest interval, the method was repeated and 8 sets (lasting 4 minutes) were performed for 1 muscle. Stretching was done on the hamstring muscle.
PNF was applied to the hamstring muscle, with a 1-day washout period in between.
Other: Static Stretching Group
Classical static stretching was applied to the hamstring muscle in the same position for 30 seconds each, 8 repetitions, a total of 4 minutes for one leg and 8 minutes for both legs, in the stance position of PNF stretching.
Static stretching was applied to the hamstring muscle, with a 1-day washout period in between.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chest Mobility Measurement 1- Axillary region
Time Frame: Duration of change in 1 day.
Normal resting tidal volume, chest width during maximum inspiration and maximum expiration were measured from the axillary region with a tape measure and recorded in centimeters.
Duration of change in 1 day.
Chest Mobility Measurement 2- Xiphoid region
Time Frame: Duration of change in 1 day.
Normal resting tidal volume, chest width during maximum inspiration and maximum expiration were measured from the xiphoid (epigastric) region with a tape measure and recorded in centimeters.
Duration of change in 1 day.
Chest Mobility Measurement 3- Subcostal region
Time Frame: Duration of change in 1 day.
Normal resting tidal volume, chest width during maximum inspiration and maximum expiration were measured from the subcostal region with a tape measure and recorded in centimeters.
Duration of change in 1 day.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Popliteal Angle Measurement
Time Frame: Duration of change in 1 day.
Hamstring muscle flexibility measurement. A digital goniometer was used.
Duration of change in 1 day.
Schober Test
Time Frame: Duration of change in 1 day.
Lumbar mobility was evaluated with the Schober Test. A tape measure was used in the testing procedure.
Duration of change in 1 day.
Posterior muscle chain mobility measurement
Time Frame: Duration of change in 1 day.
Posterior muscle chain mobility was evaluated with the Finger-Floor Distance Test. A tape measure was used in the testing procedure.
Duration of change in 1 day.
FVC Measurement
Time Frame: Duration of change in 1 day.
Respiratory Function Test. The COSMED microQuark spirometer used. Lung volume was evaluated.
Duration of change in 1 day.
FEV1 Measurement
Time Frame: Duration of change in 1 day.
Respiratory Function Test. The COSMED microQuark spirometer used. Lung volume was evaluated.
Duration of change in 1 day.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 4, 2023

Primary Completion (Actual)

March 12, 2024

Study Completion (Actual)

June 6, 2024

Study Registration Dates

First Submitted

June 7, 2024

First Submitted That Met QC Criteria

June 17, 2024

First Posted (Actual)

June 20, 2024

Study Record Updates

Last Update Posted (Actual)

June 20, 2024

Last Update Submitted That Met QC Criteria

June 17, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • PNFEffectsForCaregiver

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

It will be evaluated if the researchers are contacted via their e-mail addresses.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caregiver Burden

Clinical Trials on PNF Stretching

Subscribe